Retour
45
Également cotée sous
SNYNF
OTC
Fourchette du Jour
44,51 €
45,19 €
Fourchette 52 Semaines
43,32 €
56,93 €
Volume
2 292 264
Moyenne 50J / 200J
46,55 €
/
48,31 €
Clôture Précédente
44,77 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 14,1 | 0,3 |
| P/B | 1,5 | 2,9 |
| ROE % | 10,5 | 3,7 |
| Net Margin % | 16,7 | 3,8 |
| Rev Growth 5Y % | 4,5 | 10,0 |
| D/E | 0,3 | 0,2 |
Objectif de Cours des Analystes
Hold
57,02 €
+26.3%
Low: 48,07 €
High: 64,00 €
P/E Prévisionnel
10,6
BPA Prévisionnel
4,23 €
Croissance BPA (est.)
+0,0%
CA Est.
48 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
6,02 €
5,74 € – 6,53 €
|
58 B | 2 |
| FY2029 |
5,47 €
5,21 € – 5,93 €
|
56 B | 4 |
| FY2028 |
4,94 €
4,71 € – 5,36 €
|
53 B | 3 |
Points Clés
Revenue grew 4,50% annually over 5 years — modest growth
Earnings grew 40,52% over the past year
ROE of 10,50% — decent returns on equity
Net margin of 16,72% shows strong profitability
Debt/Equity of 0,31 — conservative balance sheet
Generating 8,89B in free cash flow
Croissance
Revenue Growth (5Y)
4,50%
Revenue (1Y)5,49%
Earnings (1Y)40,52%
FCF Growth (3Y)1,45%
Qualité
Return on Equity
10,50%
ROIC5,11%
Net Margin16,72%
Op. Margin13,58%
Sécurité
Debt / Equity
0,31
Current Ratio1,09
Interest Coverage11,73
Valorisation
P/E Ratio
14,07
P/B Ratio1,54
EV/EBITDA19,56
Dividend Yield0,05%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,49% | Revenue Growth (3Y) | 5,95% |
| Earnings Growth (1Y) | 40,52% | Earnings Growth (3Y) | 20,29% |
| Revenue Growth (5Y) | 4,50% | Earnings Growth (5Y) | 5,85% |
| Profitability | |||
| Revenue (TTM) | 46,72B | Net Income (TTM) | 7,81B |
| ROE | 10,50% | ROA | 6,16% |
| Gross Margin | 72,34% | Operating Margin | 13,58% |
| Net Margin | 16,72% | Free Cash Flow (TTM) | 8,89B |
| ROIC | 5,11% | FCF Growth (3Y) | 1,45% |
| Safety | |||
| Debt / Equity | 0,31 | Current Ratio | 1,09 |
| Interest Coverage | 11,73 | Dividend Yield | 0,05% |
| Valuation | |||
| P/E Ratio | 14,07 | P/B Ratio | 1,54 |
| P/S Ratio | 2,35 | PEG Ratio | -1,66 |
| EV/EBITDA | 19,56 | Dividend Yield | 0,05% |
| Market Cap | 109,93B | Enterprise Value | 124,06B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 46,72B | 44,29B | 41,62B | 40,56B | 39,18B |
| Net Income | 7,81B | 5,56B | 5,40B | 8,37B | 6,22B |
| EPS (Diluted) | 2,03 | 2,19 | 2,15 | 3,18 | 2,49 |
| Gross Profit | 33,79B | 31,08B | 28,99B | 28,68B | 26,92B |
| Operating Income | 6,34B | 7,25B | 6,96B | 10,16B | 8,13B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 126,81B | 132,80B | 126,46B | 126,72B | 120,24B |
| Total Liabilities | 55,10B | 54,94B | 52,11B | 51,57B | 51,21B |
| Shareholders' Equity | 71,38B | 77,51B | 74,04B | 74,78B | 68,68B |
| Total Debt | 21,79B | 17,91B | 18,70B | 21,21B | 22,41B |
| Cash & Equivalents | 7,66B | 7,44B | 8,71B | 12,74B | 10,10B |
| Current Assets | 30,95B | 42,59B | 30,66B | 34,03B | 30,56B |
| Current Liabilities | 28,35B | 29,16B | 24,19B | 23,96B | 21,30B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#515 of 1052
Activité Récente
Entré
Cash Flow Compounder
Mar 24, 2026